Literature DB >> 30825217

Nonresectional regional therapies for metastatic colorectal cancer to the liver.

Cary Jo R Schlick1, Ryan P Merkow1, David J Bentrem1,2.   

Abstract

The liver is the second leading site of colorectal cancer metastases, following the lymph nodes. Although metastatic resection for colorectal cancer liver metastases has been shown to improve survival, many patients cannot undergo surgery. Several nonsurgical therapies are available in these situations, however high-quality evidence comparing the effectiveness of these therapies is sparse. Here, we review the currently available evidence in support of nonresectional regional therapies for colorectal metastases to the liver.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  colorectal cancer; hepatic metastases; liver-directed therapy; metastatic colorectal cancer; regional therapies

Mesh:

Year:  2019        PMID: 30825217     DOI: 10.1002/jso.25423

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Shikonin in Colon Cancer.

Authors:  Yang Chen; Yun Gao; Xiaojiao Yi; Jinghui Zhang; Zhongjian Chen; Yongjiang Wu
Journal:  Front Pharmacol       Date:  2020-10-22       Impact factor: 5.810

2.  Integrated proteomics and metabolomics reveals the comprehensive characterization of antitumor mechanism underlying Shikonin on colon cancer patient-derived xenograft model.

Authors:  Yang Chen; Juan Ni; Yun Gao; Jinghui Zhang; Xuesong Liu; Yong Chen; Zhongjian Chen; Yongjiang Wu
Journal:  Sci Rep       Date:  2020-08-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.